These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6722950)

  • 1. Synthesis of six common amino acid sequence fragments of thymosins beta 4, beta 8 and beta 9 and determination of their effects on the low E-rosette forming cells of lupus nephritis patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1984 Jan; 32(1):228-36. PubMed ID: 6722950
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of synthetic thymosin beta 9 fragments on low E-rosette-forming cells of lupus nephritis patients.
    Abiko T; Sekino H
    J Appl Biochem; 1983 Dec; 5(6):446-52. PubMed ID: 6236194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of the nonatriacontapeptide corresponding to the entire amino acid sequence of calf thymosin beta 8 and its effect on the impaired T-cell subsets in patients with lupus nephritis.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1983 Apr; 31(4):1320-9. PubMed ID: 6605205
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of a thymosin beta 4-like peptide, thymosin beta Met9, and its effect on low E-rosette-forming lymphocytes of lupus nephritis patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2301-4. PubMed ID: 2279297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of synthetic thymopoietin fragments on low E-rosette forming cells in a patient with lupus nephritis.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1981 Nov; 29(11):3320-5. PubMed ID: 7337931
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and immunological effect of deacetyl-thymosin alpha 11 on low E-rosette-forming cells of a rheumatoid arthritis patient.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1985 Dec; 33(12):5419-27. PubMed ID: 3833387
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and immunological effects of thymosin alpha 1 and its fragments on inhibitory factor in minimal change nephrotic syndrome.
    Abiko T; Onodera I; Sekino H
    Chem Pharm Bull (Tokyo); 1980 Dec; 28(12):3542-8. PubMed ID: 7226295
    [No Abstract]   [Full Text] [Related]  

  • 8. Solid-phase synthesis of biologically active fragment 29-111 of rat prothymosin alpha.
    Abiko T; Sekino H
    Biotechnol Appl Biochem; 1991 Jun; 13(3):406-11. PubMed ID: 1883531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-phase syntheses of two deacetyl-thymosin alpha 1 analogues with substitution at position 21 and their effects on low E-rosette-forming lymphocytes of uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1992; 3(3-4):159-68. PubMed ID: 1303729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complete sequences of trout (Salmo gairdneri) thymosin beta 11 and its homologue thymosin beta 12.
    Yialouris PP; Coles B; Tsitsiloni O; Schmid B; Howell S; Aitken A; Voelter W; Haritos AA
    Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):385-9. PubMed ID: 1575682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the molecular size of thymosins.
    Haritos AA; Yialouris PP; Heimer EP; Felix AM; Rosemeyer MA
    FEBS Lett; 1987 Jun; 218(1):107-12. PubMed ID: 3595856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a thymosin beta 4-like peptide, deacetyl-thymosin beta Xen4, and its restorative effect on depressed lymphocyte blastogenic response to phytohemagglutinin (PHA) in uremic patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2467-71. PubMed ID: 2605693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of an immunologically active fragment analog of prothymosin alpha with enhanced enzymatic stability.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):752-6. PubMed ID: 2070460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of the octadecapeptide corresponding to positions 32 to 49 of the revised amino acid sequence of thymopoietin II and its effect on low E-rosette forming cells of an aged patient with chronic renal failure.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1982 Sep; 30(9):3271-7. PubMed ID: 7172335
    [No Abstract]   [Full Text] [Related]  

  • 15. Solid-phase synthesis of thymosin beta 4: chemical and biological characterization of the synthetic peptide.
    Low TL; Wang SS; Goldstein AL
    Biochemistry; 1983 Feb; 22(4):733-40. PubMed ID: 6838821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Thymosins.
    Hannappel E
    Ann N Y Acad Sci; 2007 Sep; 1112():21-37. PubMed ID: 17468232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symposium on renal involvement in systemic diseases. III. Lupus erythematosus. (1) Immunopathological study on lupus nephritis (author's transl)].
    Kurata N; Ofuji T
    Nihon Naika Gakkai Zasshi; 1979 Oct; 68(10):1250-3. PubMed ID: 316442
    [No Abstract]   [Full Text] [Related]  

  • 19. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
    Pozsonyi T; Jakab L; Fehér J; Cseh K
    Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-phase synthesis of thymosin alpha 1 using tert-butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin.
    Wong TW; Merrifield RB
    Biochemistry; 1980 Jul; 19(14):3233-8. PubMed ID: 7190831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.